topotecan has been researched along with AIDS-Related Opportunistic Infections in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Learned, J | 1 |
Bowers, M | 1 |
3 other study(ies) available for topotecan and AIDS-Related Opportunistic Infections
Article | Year |
---|---|
PML and a tale of two drug companies.
Topics: AIDS-Related Opportunistic Infections; Albendazole; Blood-Brain Barrier; Camptothecin; Drug Industry; Humans; Irinotecan; JC Virus; Leukoencephalopathy, Progressive Multifocal; Microsporidiosis; Polymerase Chain Reaction; Topotecan | 1995 |
Topotecan and PML: the limits of pharmaceutical industry research.
Topics: AIDS-Related Opportunistic Infections; Antineoplastic Agents; Camptothecin; Clinical Trials, Phase II as Topic; Consumer Advocacy; Drug Approval; Drug Evaluation, Preclinical; Drug Industry; Health Services Accessibility; HIV Infections; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Ovarian Neoplasms; Topotecan | 1996 |
Progressive multifocal leukoencephalopathy.
Topics: AIDS-Related Opportunistic Infections; Antineoplastic Agents; Antiviral Agents; Brain; Clinical Trials as Topic; Cytosine; Humans; Leukoencephalopathy, Progressive Multifocal; Organophosphorus Compounds; Topotecan | 1997 |